🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study objective is to confirm appropriate use and safety profile of Pra...
Status
Completed
Location
Nippon Boehringer Ingelheim Co., Ltd
Start Date
2017-07-05
Trial ID
NCT03175198
Treatments Being Tested
OPTIMAS is a large, prospective, partially blinded randomised controlled tr...
Status
Unknown
Location
Bronglais General Hospital, Hywel Dda University Health Board
Start Date
2019-06-18
Trial ID
NCT03759938
Treatments Being Tested
A phase III, randomised, parallel-group, double-blind, active controlled st...
Status
Completed
Location
1160.25.06108 Boehringer Ingelheim Investigational Site
Start Date
2004-11
Trial ID
NCT00168805
Treatments Being Tested
The purposes of this study are: 1. To evaluate the long-term safety of dab...
Status
Completed
Location
1160.71.0046 Boehringer Ingelheim Investigational Site
Start Date
2008-11
Trial ID
NCT00808067
Treatments Being Tested
The efficacy and safety of anticoagulation therapy using dabigatran in comp...
Status
Unknown
Location
Research Institute for Complex Problems of Cardiovascular Diseases
Start Date
2016-06-29
Trial ID
NCT03183843
Treatments Being Tested
The purpose of this study is to evaluate the safety of a protocol which doe...
Status
Completed
Location
Heart Institute of Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Start Date
2017-05-03
Trial ID
NCT03181386
Treatments Being Tested
The main objective of this study is to compare a Dual Antithrombotic Therap...
Status
Completed
Location
Cardiology P.C.
Start Date
2014-07-22
Trial ID
NCT02164864
This is a Phase 1, randomized, 2 way crossover, single dose, open label stu...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2018-11-21
Trial ID
NCT03742336
Treatments Being Tested
The purpose of this study is to evaluate the safety and pharmacokinetics of...
Status
Recruiting
Location
Celerion Coorporate Office Nebraska
Start Date
2026-07-13
Trial ID
NCT07629999
Treatments Being Tested
Atrial fibrillation (AF) is the most common sustained cardiac arrythmia enc...
Status
Active Not Recruiting
Location
The University of Hong Kong / Queen Mary Hospital
Start Date
2020-10-22
Trial ID
NCT04045093
Treatments Being Tested